跳至主要内容
临床试验/CTRI/2022/06/042983
CTRI/2022/06/042983尚未招募2 期

Clinical study to evaluate the combined effect of Harataladi lepa and Bakuchi churna capsule in the management of Switra (Vitiligo) in children

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年6月6日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
The increase in pigmentation of Vitiligo patches will be measured before ad after intervention

研究概览

简要总结

The objective of the study is to evaluate the combined effect of Harataladi lepa and Bakuchi churna cpasule in Switra (Vitiligo) in children. 30 subjects with Switra will be administered with Bakuchi capsule internally along with application of Harataladi lepa externally for a period of 30 days. The subjects will be assessed for primary outcome measures on 0th day, 31st day and 61st day.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
6.00 Year(s) 至 16.00 Year(s)(—)
性别
All

入选标准

  • The children of either gender between the age group of 6-16 years fulfilling the diagnostic criteria of Vitiligo.
  • Children, whose parents are willing to participate them in the study after giving informed parent consent.

排除标准

  • Vitiligo patches developed as a complication of burns.
  • Children diagnosed with autoimmune disorders, neurological disorders, endocrine disorders, leprosy and tuberculosis.

结局指标

主要结局

The increase in pigmentation of Vitiligo patches will be measured before ad after intervention

时间窗: 30 days

次要结局

  • Reduction in the size of Vitiligo patches(30 days)

研究者

发起方
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验